drugset / Trial / NCT01797081
BOTOX® in the Treatment of Crow's Feet Lines in Japan
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared to placebo for the treatment of Crow's Feet Lines (Lateral Canthus Rhytides).
Timeline
- Start
- 2013-01-31
- Primary completion
- 2013-07-18
- Completion
- 2014-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 12 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 24 iu | Other |